Article(id=1330233710286320595, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.02.009, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1695657600000, receivedDateStr=2023-09-26, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795082031078, onlineDateStr=2026-11-19, pubDate=1707494400000, pubDateStr=2024-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795082031078, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795082031078, creator=13701087609, updateTime=1795082031078, updator=13701087609, issue=Issue{id=1330233670775976505, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='2', pageStart='165', pageEnd='308', issueExtLink='null', onlineDate='null', pubDate='1707494400000', pubDateStr='2024-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795082021659, creator='13701087609', updateTime=1795082707094, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330236546143334510, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330236546143334511, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=227, endPage=234, ext={EN=ArticleExt(id=1330233710508618708, articleId=1330233710286320595, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Synthesis of the Related Substances of Ceritinib, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=

Eight related substances of ceritinib(1) were prepared according to its structure and synthetic process, namely 5-chloro-2-isopropoxy-N-[2-(isopropylsulfonyl)phenyl]pyrimidin-4-amine(related substance A), 5-chloro-4-[[2-(isopropylsulfonyl)phenyl]amino]pyrimidin-2-ol(related substance B), 5-chloro-N2-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N4-[2-(isopropylsulfinyl)phenyl]pyrimidine-2,4-diamine(related substance C), 5-chloro-N2-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N4-[2-(propylsulfonyl)phenyl]pyrimidine-2,4-diamine(related substance D), 5-chloro-N4-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N2-[2-(isopropylsulfonyl)phenyl]-pyrimidine-2,4-diamine(related substance E), 2-[[5-chloro-4-[[2-(isopropylsulfonyl)phenyl]amino]pyrimidin-2-yl]amino]-4-methyl-5-(piperidin-4-yl)phenol(related substance F), 4-[4-[4-[[5-chloro-4-[[2-(isopropylsulfonyl)-phenyl]amino]pyrimidin-2-yl]amino]-5-isopropoxy-2-methylphenyl]piperidin-1-yl]pentan-2-one(related substance G),5-chloro-N2-[4-[1-[5-chloro-4-[[2-(isopropylsulfonyl)phenyl]amino]pyrimidin-2-yl]piperidin-4-yl]-2-isopropoxy-5-methylphenyl]-N4-[2-(isopropylsulfonyl)phenyl]pyrimidine-2,4-diamine(related substance H). And their structures were confirmed by 1H NMR and MS.

, authors=Zhen LI, Sujie CHEN, Guoquan ZHAO, authorsList=Zhen LI, Sujie CHEN, Guoquan ZHAO, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330233710798025685, articleId=1330233710286320595, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=塞瑞替尼有关物质的合成, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

根据塞瑞替尼(1)结构及合成工艺,制备了8个有关物质:5-氯-2-异丙氧基-N-[2-(异丙基磺酰基)苯基]-4-嘧啶胺(有关物质A)、5-氯-4-[[2-(异丙基磺酰基)苯基]氨基]-2-嘧啶醇(有关物质B)、5-氯-N2-[2-异丙氧基-5-甲基-4-(哌啶-4-基)苯基]-N4-[2-(异丙基亚硫酰基)苯基]-2,4-嘧啶二胺(有关物质C)、5-氯-N2-[2-异丙氧基-5-甲基-4-(哌啶-4-基)苯基]-N4-[2-(丙基磺酰基)苯基]-2,4-嘧啶二胺(有关物质D)、5-氯-N4-[2-异丙氧基-5-甲基-4-(哌啶-4-基)苯基]-N2-[2-(异丙基磺酰基)苯基]-2,4-嘧啶二胺(有关物质E)、2-[[5-氯-4-[[2-(异丙基磺酰基)苯基]-氨基]嘧啶-2-基]氨基]-4-甲基-5-(哌啶-4-基)苯酚(有关物质F)、4-[4-[4-[[5-氯-4-[[2-(异丙基磺酰基)苯基]-氨基]-嘧啶-2-基]氨基]-5-异丙氧基-2-甲基苯基]哌啶-1-基]戊-2-酮(有关物质G)、5-氯-N2-[4-[1-[5-氯-4-[[2-(异丙基磺酰基)苯基]胺基]嘧啶-2-基]哌啶-4-基]-2-异丙氧基-5-甲基苯基]-N4-[2-(异丙基磺酰基)苯基]-2,4-嘧啶二胺(有关物质H),且经1H NMR和MS结构确证。

, authors=李振, 陈素洁, 赵国权, authorsList=李振, 陈素洁, 赵国权, authorCompany=null, correspAuthors=null, authorNote=

李振(1983—),男,高级工程师,从事药物合成和新药研发。E-mail:

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=Ma9wzlHLve7zkhODVjDLFA==, magXml=qnQIwCfbD0SaTtL1ubPygA==, pdfUrl=null, pdf=hh5zA+ppXlAbCANc1DlJlA==, pdfFileSize=2186327, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=D1pYqmOWTec2Cc0jMj1vHQ==, mapNumber=null, fund=null)}, authors=[Author(id=1330233711079044058, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lizhensynchem@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233711200678876, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711079044058, language=EN, stringName=Zhen LI, firstName=Zhen, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233711267787741, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711079044058, language=CN, stringName=李振, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=南京科默生物医药有限公司,江苏 南京 210046, bio={"content":"

李振(1983—),男,高级工程师,从事药物合成和新药研发。E-mail:

"}, bioImg=null, bioContent=

李振(1983—),男,高级工程师,从事药物合成和新药研发。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233711011935190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, xref=null, ext=[AuthorCompanyExt(id=1330233711020323799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046), AuthorCompanyExt(id=1330233711028712408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京科默生物医药有限公司,江苏 南京 210046)])]), Author(id=1330233711343285215, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233711410394081, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711343285215, language=EN, stringName=Sujie CHEN, firstName=Sujie, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233711473308642, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711343285215, language=CN, stringName=陈素洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=南京科默生物医药有限公司,江苏 南京 210046, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233711011935190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, xref=null, ext=[AuthorCompanyExt(id=1330233711020323799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046), AuthorCompanyExt(id=1330233711028712408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京科默生物医药有限公司,江苏 南京 210046)])]), Author(id=1330233711544611812, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233711615914982, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711544611812, language=EN, stringName=Guoquan ZHAO, firstName=Guoquan, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233711691412455, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711544611812, language=CN, stringName=赵国权, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=南京科默生物医药有限公司,江苏 南京 210046, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233711011935190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, xref=null, ext=[AuthorCompanyExt(id=1330233711020323799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046), AuthorCompanyExt(id=1330233711028712408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京科默生物医药有限公司,江苏 南京 210046)])])], keywords=[Keyword(id=1330233711783687144, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, language=EN, orderNo=1, keyword=ceritinib), Keyword(id=1330233711850796009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, language=EN, orderNo=2, keyword=ALK inhibitor), Keyword(id=1330233711917904874, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, language=EN, orderNo=3, keyword=related substance), Keyword(id=1330233711980819435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, language=EN, orderNo=4, keyword=synthesis), Keyword(id=1330233712047928300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, language=CN, orderNo=1, keyword=塞瑞替尼), Keyword(id=1330233712102454253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, language=CN, orderNo=2, keyword=ALK抑制剂), Keyword(id=1330233712161174510, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, language=CN, orderNo=3, keyword=有关物质), Keyword(id=1330233712207311855, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, language=CN, orderNo=4, keyword=合成)], refs=[Reference(id=1330233712295392240, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Highlights of prescribing information [EB/OL].[2022-12-12].https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205755s000lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1330233712349918193, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=MARSILJE T H, PEI W, CHEN B, et al.Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase(ALK)inhibitor 5-chloro-N2-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)-phenyl]-N4-[2-(isopropylsulfonyl)-phenyl]pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials [J].J Med Chem, 2013, 56(14): 5675-5690., articleTitle=null, refAbstract=null), Reference(id=1330233712417027058, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=葛丹丹,宫平.色瑞替尼[J].中国药物化学杂志,2014,24(5):420., articleTitle=null, refAbstract=null), Reference(id=1330233712496718835, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=甘宗捷,余瑜.色瑞替尼合成路线图解[J].中国医药工业杂志,2017,48(4):601-604., articleTitle=null, refAbstract=null), Reference(id=1330233712572216308, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=董岩岩.一种2,5-二氯-N-(2-(异丙基磺酰基)苯基)嘧啶-4-胺的制备方法:中国,106854182B [P].2020-02-07., articleTitle=null, refAbstract=null), Reference(id=1330233714195411957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=宋金峰,唐文生,何训贵,等.制备色瑞替尼的新中间体及其制备方法:中国,104447515B [P].2017-06-16., articleTitle=null, refAbstract=null), Reference(id=1330233714275103734, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=诺华股份有限公司.5-氯-N2-(2-异丙氧基-5-甲基-4-哌啶-4-基-苯基)-N4-[2-(丙烷-2-磺酰基)-苯基]-嘧啶-2,4-二胺的结晶形式:中国,103282359A [P].2013-09-04., articleTitle=null, refAbstract=null), Reference(id=1330233714367378423, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=陈庆财,李晓昕,孙敏,等.一种塞瑞替尼的制备方法:中国,111410649B [P].2022-09-02., articleTitle=null, refAbstract=null), Reference(id=1330233714463847416, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=GRAY N, ZHANG T H, KWIATKOWSKI N, et al.Inhibitors of cyclin-dependent kinase 12(CDK12) and uses thereof: WO, 2018098361 [P].2018-05-31., articleTitle=null, refAbstract=null), Reference(id=1330233714530956281, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=SOUJANYA V, VIJAY B, CHIDANANDA S R, et al.Forced degradation of Ceritinib under stress conditions: structural interpretation of novel degradants using HR-MS/MS and NMR [J].Mater Today, 2020, 33(5): 2067-2076., articleTitle=null, refAbstract=null), Reference(id=1330233714598065146, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=冯亚兵,史科慧,朱文峰.色瑞替尼中间体及其制备方法:中国,107602483B [P].2020-04-03., articleTitle=null, refAbstract=null), Reference(id=1330233714660979707, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=黎兴术,姚晗,安佰娇,等.一种新型亚磺酰基苯胺基的嘧啶衍生物及其在制备抗肿瘤药物中的应用:中国,113501808A [P].2021-10-15., articleTitle=null, refAbstract=null), Reference(id=1330233714723894268, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=SIDDIQUI-JAIN A, WARNER S, DHRUV H.Aminopyrim idinylaminobenzonitrile derivatives as NEK2 inhibitors: WO, 2021155185 [P].2021-08-05., articleTitle=null, refAbstract=null), Reference(id=1330233714803586045, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Novartis Pharmaceuticals, Co. Ltd.Antineoplastics/tyrosine kinase inhibitor Seritinib tablets [EB/OL].[2022-12-12].https://www.info.pmda.go.jp/go/interview/1/300242_4291044F1022_1_ZYK_1F.pdf., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330233711011935190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, xref=null, ext=[AuthorCompanyExt(id=1330233711020323799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046), AuthorCompanyExt(id=1330233711028712408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京科默生物医药有限公司,江苏 南京 210046)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.02.009, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.02.009, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.02.009, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.02.009, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1707494400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
塞瑞替尼有关物质的合成
李振 , 陈素洁 , 赵国权
中国医药工业杂志 | 研究论文 2024,55(2): 227-234
收起
收藏切换
中国医药工业杂志 |研究论文 2024 , 55 (2) : 227 -234
塞瑞替尼有关物质的合成
全屏
[Author(id=1330233711079044058, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lizhensynchem@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233711200678876, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711079044058, language=EN, stringName=Zhen LI, firstName=Zhen, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233711267787741, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711079044058, language=CN, stringName=李振, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=南京科默生物医药有限公司,江苏 南京 210046, bio={"content":"

李振(1983—),男,高级工程师,从事药物合成和新药研发。E-mail:

"}, bioImg=null, bioContent=

李振(1983—),男,高级工程师,从事药物合成和新药研发。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233711011935190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, xref=null, ext=[AuthorCompanyExt(id=1330233711020323799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046), AuthorCompanyExt(id=1330233711028712408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京科默生物医药有限公司,江苏 南京 210046)])]), Author(id=1330233711343285215, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233711410394081, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711343285215, language=EN, stringName=Sujie CHEN, firstName=Sujie, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233711473308642, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711343285215, language=CN, stringName=陈素洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=南京科默生物医药有限公司,江苏 南京 210046, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233711011935190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, xref=null, ext=[AuthorCompanyExt(id=1330233711020323799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046), AuthorCompanyExt(id=1330233711028712408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京科默生物医药有限公司,江苏 南京 210046)])]), Author(id=1330233711544611812, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233711615914982, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711544611812, language=EN, stringName=Guoquan ZHAO, firstName=Guoquan, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233711691412455, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, authorId=1330233711544611812, language=CN, stringName=赵国权, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=南京科默生物医药有限公司,江苏 南京 210046, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233711011935190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, xref=null, ext=[AuthorCompanyExt(id=1330233711020323799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046), AuthorCompanyExt(id=1330233711028712408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233710286320595, companyId=1330233711011935190, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京科默生物医药有限公司,江苏 南京 210046)])])]
李振 , 陈素洁, 赵国权
作者信息
  • 南京科默生物医药有限公司,江苏 南京 210046
作者简介:

李振(1983—),男,高级工程师,从事药物合成和新药研发。E-mail:

Synthesis of the Related Substances of Ceritinib
Zhen LI , Sujie CHEN, Guoquan ZHAO
Affiliations
  • Nanjing Caremo Biomedical Co., Ltd., Nanjing 210046
出版时间: 2024-02-10 doi: 10.16522/j.cnki.cjph.2024.02.009
文章导航
收藏切换

根据塞瑞替尼(1)结构及合成工艺,制备了8个有关物质:5-氯-2-异丙氧基-N-[2-(异丙基磺酰基)苯基]-4-嘧啶胺(有关物质A)、5-氯-4-[[2-(异丙基磺酰基)苯基]氨基]-2-嘧啶醇(有关物质B)、5-氯-N2-[2-异丙氧基-5-甲基-4-(哌啶-4-基)苯基]-N4-[2-(异丙基亚硫酰基)苯基]-2,4-嘧啶二胺(有关物质C)、5-氯-N2-[2-异丙氧基-5-甲基-4-(哌啶-4-基)苯基]-N4-[2-(丙基磺酰基)苯基]-2,4-嘧啶二胺(有关物质D)、5-氯-N4-[2-异丙氧基-5-甲基-4-(哌啶-4-基)苯基]-N2-[2-(异丙基磺酰基)苯基]-2,4-嘧啶二胺(有关物质E)、2-[[5-氯-4-[[2-(异丙基磺酰基)苯基]-氨基]嘧啶-2-基]氨基]-4-甲基-5-(哌啶-4-基)苯酚(有关物质F)、4-[4-[4-[[5-氯-4-[[2-(异丙基磺酰基)苯基]-氨基]-嘧啶-2-基]氨基]-5-异丙氧基-2-甲基苯基]哌啶-1-基]戊-2-酮(有关物质G)、5-氯-N2-[4-[1-[5-氯-4-[[2-(异丙基磺酰基)苯基]胺基]嘧啶-2-基]哌啶-4-基]-2-异丙氧基-5-甲基苯基]-N4-[2-(异丙基磺酰基)苯基]-2,4-嘧啶二胺(有关物质H),且经1H NMR和MS结构确证。

塞瑞替尼  /  ALK抑制剂  /  有关物质  /  合成

Eight related substances of ceritinib(1) were prepared according to its structure and synthetic process, namely 5-chloro-2-isopropoxy-N-[2-(isopropylsulfonyl)phenyl]pyrimidin-4-amine(related substance A), 5-chloro-4-[[2-(isopropylsulfonyl)phenyl]amino]pyrimidin-2-ol(related substance B), 5-chloro-N2-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N4-[2-(isopropylsulfinyl)phenyl]pyrimidine-2,4-diamine(related substance C), 5-chloro-N2-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N4-[2-(propylsulfonyl)phenyl]pyrimidine-2,4-diamine(related substance D), 5-chloro-N4-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N2-[2-(isopropylsulfonyl)phenyl]-pyrimidine-2,4-diamine(related substance E), 2-[[5-chloro-4-[[2-(isopropylsulfonyl)phenyl]amino]pyrimidin-2-yl]amino]-4-methyl-5-(piperidin-4-yl)phenol(related substance F), 4-[4-[4-[[5-chloro-4-[[2-(isopropylsulfonyl)-phenyl]amino]pyrimidin-2-yl]amino]-5-isopropoxy-2-methylphenyl]piperidin-1-yl]pentan-2-one(related substance G),5-chloro-N2-[4-[1-[5-chloro-4-[[2-(isopropylsulfonyl)phenyl]amino]pyrimidin-2-yl]piperidin-4-yl]-2-isopropoxy-5-methylphenyl]-N4-[2-(isopropylsulfonyl)phenyl]pyrimidine-2,4-diamine(related substance H). And their structures were confirmed by 1H NMR and MS.

ceritinib  /  ALK inhibitor  /  related substance  /  synthesis
李振, 陈素洁, 赵国权. 塞瑞替尼有关物质的合成. 中国医药工业杂志, 2024 , 55 (2) : 227 -234 . DOI: 10.16522/j.cnki.cjph.2024.02.009
Zhen LI, Sujie CHEN, Guoquan ZHAO. Synthesis of the Related Substances of Ceritinib[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (2) : 227 -234 . DOI: 10.16522/j.cnki.cjph.2024.02.009

参考文献 引证文献
排序方式:
[1]
FDA.Highlights of prescribing information [EB/OL].[2022-12-12].https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205755s000lbl.pdf.
[2]
MARSILJE T H, PEI W, CHEN B, et al.Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase(ALK)inhibitor 5-chloro-N2-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)-phenyl]-N4-[2-(isopropylsulfonyl)-phenyl]pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials [J].J Med Chem, 2013, 56(14): 5675-5690.
[3]
葛丹丹,宫平.色瑞替尼[J].中国药物化学杂志,2014,24(5):420.
[4]
甘宗捷,余瑜.色瑞替尼合成路线图解[J].中国医药工业杂志,2017,48(4):601-604.
[5]
董岩岩.一种2,5-二氯-N-(2-(异丙基磺酰基)苯基)嘧啶-4-胺的制备方法:中国,106854182B [P].2020-02-07.
[6]
宋金峰,唐文生,何训贵,等.制备色瑞替尼的新中间体及其制备方法:中国,104447515B [P].2017-06-16.
[7]
诺华股份有限公司.5-氯-N2-(2-异丙氧基-5-甲基-4-哌啶-4-基-苯基)-N4-[2-(丙烷-2-磺酰基)-苯基]-嘧啶-2,4-二胺的结晶形式:中国,103282359A [P].2013-09-04.
[8]
陈庆财,李晓昕,孙敏,等.一种塞瑞替尼的制备方法:中国,111410649B [P].2022-09-02.
[9]
GRAY N, ZHANG T H, KWIATKOWSKI N, et al.Inhibitors of cyclin-dependent kinase 12(CDK12) and uses thereof: WO, 2018098361 [P].2018-05-31.
[10]
SOUJANYA V, VIJAY B, CHIDANANDA S R, et al.Forced degradation of Ceritinib under stress conditions: structural interpretation of novel degradants using HR-MS/MS and NMR [J].Mater Today, 2020, 33(5): 2067-2076.
[11]
冯亚兵,史科慧,朱文峰.色瑞替尼中间体及其制备方法:中国,107602483B [P].2020-04-03.
[12]
黎兴术,姚晗,安佰娇,等.一种新型亚磺酰基苯胺基的嘧啶衍生物及其在制备抗肿瘤药物中的应用:中国,113501808A [P].2021-10-15.
[13]
SIDDIQUI-JAIN A, WARNER S, DHRUV H.Aminopyrim idinylaminobenzonitrile derivatives as NEK2 inhibitors: WO, 2021155185 [P].2021-08-05.
[14]
Novartis Pharmaceuticals, Co. Ltd.Antineoplastics/tyrosine kinase inhibitor Seritinib tablets [EB/OL].[2022-12-12].https://www.info.pmda.go.jp/go/interview/1/300242_4291044F1022_1_ZYK_1F.pdf.
2024年第55卷第2期
34
10
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.02.009
  • 接收时间:2023-09-26
  • 首发时间:2026-11-19
  • 出版时间:2024-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-09-26
基金
作者信息
    南京科默生物医药有限公司,江苏 南京 210046
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.02.009
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏